ABSTRACT. The lungs play an important role in the metabolism of vasoactive substances including endogenous amines. The role of pulmonary clearance of circulating norepinephrine has not been well defined in the young lamb (7-8 d of age). Using radiolabeled tracer norepinephrine in acutely instrumented lambs, we determined the in vivo pulmonary clearance and spillover rate of norepinephrine under baseline and hypoxic conditions. The fractional extraction of norepinephrine, the percent removed on a single pass through the pulmonary circulation, was 23 f 2%. The corresponding pulmonary clearance rate was 61 f 10 mL/ kglmin and the net pulmonary norepinephrine removal rate was 0.41 f 0.14 nmol/kg/min. This clearance represented over 70% of whole body norepinephrine clearance. The spillover of synaptic norepinephrine was 0.22 f 0.13 nmol/ kg/min. During hypoxia, animals showed significant increases in pulmonary artery pressure and resistance. Fractional extraction of norepinephrine decreased to 16 f 3%, p < 0.005. Pulmonary clearance decreased to 31 f 7 mL/ kg/min, and net pulmonary norepinephrine removal rate decreased to 0.27 f 0.07 nmol/kg/min. These results demonstrate that pulmonary clearance plays a significant role in norepinephrine clearance in 1-wk-old lambs. Alteration of norepinephrine clearance during physiologic states such as hypoxia may be important in the pathophysiology of altered pulmonary vascular resistance in newborn animals. 29: 93-97, 1991) Abbreviations ANOVA, analysis of variance In many species including rat, rabbit, dog, and man, the lungs play a significant role in norepinephrine clearance (1-4). The endothelial cells lining the small pre-and postcapillary vessels of the lung remove norepinephrine from the blood by a sodiumand temperature-dependent saturable mechanism with a Km of approximately 1 pM (5-7). This clearance is unique, having characteristics of both neuronal and extraneuronal uptake systems. For example, it is inhibited by cocaine and imipramine (inhibitors of neuronal uptake) as well as normetanephrine (a nonneuronal inhibitor) (6).
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In the literature to date, pulmonary fractional extraction of norepinephrine has ranged from 7 to 65%; that is, 7 to 65% of total circulating norepinephrine is removed on a single pass through the pulmonary circulation (8) (9) (10) . Studies have been conducted using both in vitro (isolated perfused lung) and in vivo 9 techniques. Isolated perfused lung methods have been the major focus of investigations into pulmonary norepinephrine clearance; however, surgical denemation and relatively low flow rates have made extrapolation of these results to in vivo systems difficult (1 1, 12). Similarly, in vivo studies based solely on arteriovenous differences in endogenous norepinephrine concentrations are difficult to interpret and may underestimate the actual clearance of norepinephrine. Therefore, in vivo methods using radioactive tracers are preferred (2) . These methods allow determination of both clearance and spillover of synaptic norepinephrine (2) . In vivo adult animal studies using tritiated norepinephrine demonstrate fractional extractions of norepinephrine of 35 to 60% (1 3, 14) .
Various pathophysiologic conditions may alter the pulmonary clearance and spillover of norepinephrine including hypoxia, hyperoxia, and pulmonary hypertension (1 5-1 7). Little is known about the effect of development on pulmonary norepinephrine clearance. The available literature on pulmonary clearance in developing animals comes from rabbit studies using in vitro, isolated perfused lung techniques (16, 18) and comparison of arteriovenous differences in human infants (1 9). The purpose of our study was to determine the pulmonary clearance and production rate of norepinephrine in young animals in vivo using radiotracer techniques and to determine the effect of hypoxia on pulmonary norepinephrine clearance and spillover.
MATERIALS AND METHODS
Animal studies. After approval by the Animal Care and Use Review Committee, lambs ( n = 8) were housed in metabolic cages with the ewe and allowed to nurse ad libitum while acclimating to the laboratory environment for 1 to 2 d before the study. On the day of the study, lambs were sedated with 15 mg/ kg ketamine intramuscularly followed by continuous i.v. ketamine at 10 mg/kg/h. After tracheostomy under local anesthesia, lambs were paralyzed with pancuronium bromide (0.1 mg/kg) and ventilated with pressure-controlled ventilators. Initial ventilator settings were peak inspiratory pressure, 20 cm H20; end expiratory pressure, 2 cm H20; respiratory rate, 30 breaths/min; inspiratory time, 0.7 s; and fractional inspired oxygen, 0. uously by direct pressure monitoring and intermittently as necessary with fluoroscopy. A peripheral i.v. catheter was inserted into the saphenous vein for infusion of tracer. Glucose was infused at a rate of 6 mg/kg/min. Total i.v. fluids including glucose, ketamine, hormone, and normal saline to maintain patency of catheters were given at a rate equal to 6.25 mL/kg/h.
After 1 h of stabilization, an infusion of 7-3H-l-norepinephrine (New England Nuclear, Boston, MA; 14.2 Ci/mmol) was begun at 0.6 pCi/kg/min (0.046 ccg/kg/min) and continued throughout the study. Heart rate, blood pressure, cardiac output, and pulmonary artery pressure were monitored continuously and recorded every 20 min throughout the study. After measurement of hemodynamic variables, simultaneous left ventricular and pulmonary artery blood samples were drawn for catecholamines, tracer analysis, and arterial blood gas determinations. All blood samples were immediately replaced with an equal quantity of heparinized maternal blood. After 1 h of tracer infusion, the lambs were made hypoxic by decreasing fractional inspired oxygen to 12-14% with the addition of nitrogen to the ventilation mixture. Sampling and hemodynamic monitoring was continued every 20 min during the subsequent 1-h period of hypoxia.
After completion of the hypoxia studies, all lambs were killed by i.v. pentobarbital overdose (100 mg/kg). Before overdose, radioactive microspheres of 15 pm diameter were infused into two lambs during hypoxia to determine blood flow distribution and rule out major intracardiac shunts. Microspheres labeled with 4 6 S~ and 47Co were injected simultaneously over 2 min into the left ventricle and superior vena cava, respectively. At autopsy, the lungs were removed, and the carcass and lungs were incinerated and processed separately for measurement of radioactivity.
Analytical Techniques. Immediately after sampling, blood was placed in test tubes containing reduced glutathione and EGTA. Samples were centrifuged at 4°C at 2500 X g for 5 min. The plasma was separated and stored at -70'C until assay within 2 wk.
Tracer analysis. For separation of tritiated norepinephrine from radioactive metabolites, plasma was extracted with alumina (20) . One half mL of plasma was added to 50 mg of acid-washed alumina, vortexed with Tris-EDTA buffer pH 8.8, and centrifuged, and the supernatant discarded. The alumina was washed three times with water, and 0.6 mL of 0.1 N perchloric acid was added and vortexed. After centrifugation, 0.4 mL of the eluate was added to 10 mL Scintiverse (Fisher Scientific, Springfield, NJ) scintillation cocktail and counted using a P-scintillation counter. Samples from individual animals were all extracted in the same assay along with an aliquot of the infusate. Recovery of radiolabeled norepinephrine averaged 60-70% as previously reported (20) .
Catecholamine analysis. Plasma catecholamines were assayed in duplicate using a modification of the Peuler and Johnson method of catecholamine quantification (21) . Samples from individual animals were all measured in the same assay. The sensitivity for norepinephrine is 0.12-0.24 nmol/L and for epinephrine is 110-220 pmol/L, and the inter-and intraassay variabilities in our laboratory are each less than 5%.
Microsphere techniques. After processing, 10 carcass aliquots of known mass and the entire lung were counted in a multichannel gamma spectrometer. Shunt fraction is expressed as the percentage of isotope crossover between carcass and lung.
Data analysis. Equations used for calculation of fractional extraction, specific organ clearance, and spillover have been described previously (8, 22) .
Fractional extraction of norepinephrine (FextNE) was determined as follows:
where 'HNEpA and 'HNELV are the tracer concentrations in the pulmonary artery and left ventricle, respectively. Pulmonary clearance of norepinephrine (C1) was determined as follows: CI (mL/kg/min) = FextNE X PPF (mL/kg/min) (2) where FextNE is derived in equation 1 and pulmonary plasma flow (PPF) is the cardiac output multiplied by (1 -hematocrit) and normalized to body weight.
Whole body plasma clearance rate (PCR) of norepinephrine was determined as follows:
where 3HNE tracer (cpm/mL) is the radiolabeled norepinephrine concentration in the infusion and d3HNEp, (cpm/mL) is the difference between the radiolabeled norepinephrine concentration in the pulmonary artery at each sampling time and preinfusion (i.e. background). Net pulmonary removal of norepinephrine was determined as follows:
where NEpA is the endogenous norepinephrine concentration in the pulmonary artery and C1 is the pulmonary clearance determined in equation 2.
Spillover of norepinephrine (Sp), reflecting egress from the synaptic cleft of norepinephrine released by pulmonary postganglionic sympathetic nerves, was determined as follows:
where NELv is the endogenous norepinephrine concentration in the left ventricle.
Statistical analysis. All catecholamine concentrations were log transformed before statistical analysis and are expressed as geometric mean k SEM, pg/mL. All biophysical measurements are presented as mean + SEM. Comparisons of hemodynamic pa- blood gases, systemic systolic blood pressure, and pulmonary artery norepinephrine and epinephrine concentrations within expected ranges (23). These data are shown as preinfusion values in Table I . Plasma radioactivity and pulmonary clearance estimates during the tracer infusion are shown in Figure 1 . Consistent with previous studies, the radiolabeled norepinephrine did not elevate the norepinephrine concentration significantly nor did it produce pharmacologic effects (2) . During the infusion of radiolabeled norepinephrine, there were no changes in heart rate, blood pressure, and cardiac output when compared by one-way AN-OVA. By 20 min of infusion during the baseline period, the plasma radioactivity had not yet reached steady state (Fig. 1A) .
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By 40 min, however, all animals had steady state plasma radioactivity. The simultaneous fractional extractions are shown in Figure 1 B. The pulmonary clearance and whole body clearance estimates are shown in Figure 2 . Because radioactivity, fractional extraction, and clearance were constant after 20 min (ANOVA), the averages were pooled from the 40-and 60-min data. Mean fractional extraction of norepinephrine was 23 * 2% and pulmonary norepinephrine clearance was 61 f 10 mL/kg/min.
Whole body plasma clearance of norepinephrine was 78 + 3 mL/kg/min. Thus, under baseline conditions, pulmonary clearance constituted over 70% of whole body plasma clearance. Net pulmonary norepinephrine removal rate, which is a reflection of the pulmonary clearance and the concentration of circulating amine, was 0.41 + 0.14 nmol/kg/min. Pulmonary norepinephrine spillover is shown in Figure 3 . The spillover rate during the baseline period from 40 to 60 min was 0.22 k 0.14 nmol/kg/ min.
After the onset of hypoxia, Po, decreased significantly from 18.5 to 6 kPa (139 to 45 mm Hg, p < 0.001); Pcoz decreased slightly ( p < 0.05). Pulmonary artery pressure and calculated pulmonary vascular resistance are shown in Figure 4 . During the baseline norepinephrine tracer infusion, both pulmonary artery pressure and vascular resistance were stable. After the onset of hypoxia, mean pulmonary artery pressure rose steadily from 12 to 21 mm Hg, and pulmonary vascular resistance rose from 0.027 to 0.046 mm Hg/mL/kg/min ( p < 0.005). Systolic blood pressure also increased significantly from 126 to 145 mm Hg and heart rate increased from 203 to 230 beats/min (Table I) (Table 1) . During hypoxia, fractional extraction of norepinephrine decreased significantly from 23 f 2 to 16 + 3% ( p < 0.05; Fig. 1B) . Pulmonary norepinephrine clearance decreased from 6 1 k 10 to 3 1 f 7 mL/kg/min ( p < 0.05, Fig. 2 A ) and represented only 40% of whole body plasma clearance of norepinephrine, which did not change (Fig. 2B) . Net pulmonary norepinephrine removal decreased from 0.41 k 0.14 to 0.27 f 0.7 nmol/kg/min (45 f 12 ng/kg/min; p < 0.05). Pulmonary norepinephrine spillover was more variable between subjects and did not change (Fig. 3) . Microsphere determination of blood flow distribution showed a small (10%) left to right shunt consistent with previous descriptions of bronchial flow and no right to left shunt within the limits of detection (24) .
DISCUSSION
In our study, we demonstrated significant pulmonary extraction of circulating norepinephrine in I-wk-old lambs. Although the in vitro pulmonary clearance of norepinephrine has been demonstrated previously, these data compose the first description of pulmonary norepinephrine clearance in developing animals using in vivo radiolabeled tracer techniques. We also demonstrated a significant diminution in fractional extraction of norepinephrine with hypoxia. With the decrease in fractional extraction, pulmonary norepinephrine clearance decreased but spillover was unchanged.
Pulmonary clearance of norepinephrine has been determined in vitro and in vivo. Isolated perfused lung preparations using adult animals have suggested baseline fractional extraction rates of 30-53% (1 1, 12, 18 ). These studies demonstrate that pulmonary clearance of norepinephrine decreases with increasing concentrations of norepinephrine, suggesting that pulmonary uptake of norepinephrine is saturable at high rates of substrate delivery (1 1). In vivo studies based solely on arteriovenous differences of endogenous amine are difficult to interpret because the rich postganglionic sympathetic innervation of the lung may release norepinephrine into the blood, masking clearance. Based on arteriovenous differences of endogenous amine alone, the apparent pulmonary fractional extraction of norepinephrine in humans has varied from 0 to 27% under baseline conditions (1 7, 24-26). Data from in vivo protocols using nonradioactive norepinephrine infusions require doses that result in significant pharmacologic effects (2, 10) . To avoid the pharmacologic effects of infused norepinephrine, steady state radiolabeled l-norepinephrine is currently the preferred method of determining norepinephrine clearance and spillover in vivo. Small amounts of exogenous radiolabeled norepinephrine may be detected without significantly increasing the circulating hormone concentration. Using tritium-labeled norepinephrine in adults, Esler and colleagues estimated pulmonary fractional extraction at 4 1 %, corresponding to a pulmonary norepinephrine clearance of 906 mL/min and spillover of 0.94 nmol/min (12) .
Pathophysiologic conditions including hypoxia, hyperoxia, drugs, and pulmonary hypertension alter pulmonary clearance of norepinephrine. Gewitz and Tait (16) demonstrated a decrease in in vitro pulmonary norepinephrine clearance in rabbit pups after 3 d of hypoxia. Hyperoxia exceeding 24 h also decreases pulmonary clearance of norepinephrine, suggesting that norepinephrine clearance may be a marker for oxygen-induced pulmonary endothelial damage (1 5). In vivo studies also suggest that norepinephrine clearance may be used as a marker for pulmonary toxicity of drugs (14) . Based on arteriovenous differences of endogenous amine, pulmonary hypertension decreases pulmonary norepinephrine clearance in both adults and children to values approaching zero clearance (17, 19, 27) . It is unclear whether these findings represent a decrease in pulmonary clearance or an increase in spillover rate.
We showed a decreased fractional extraction of norepinephrine with hypoxia and elevated pulmonary artery pressure. It is important to note that only a modest degree of hypoxia was used to avoid major alterations in acid-base status. Nonetheless, a significant impact on the fractional extraction of norepinephrine and pulmonary norepinephrine clearance was observed. In contrast to previous studies, the duration of hypoxia and increased pulmonary artery pressure in our study was measured in minutes, not days or longer. By 40 min, fractional extraction was significantly decreased. This rapid decrease in fractional extraction cannot be attributed to vascular endothelial remodeling, as in chronic pulmonary hypertension, and most likely represents intrapulmonary shunt& of norepinephrine away from ihe pericapillary vessels active in norepinephrine metabolism. The decrease also may represent a saturation of the clearance mechanism or an effect of decreased oxygen on the uptake kinetics; however, the mild degree of hypoxia used and the mild increase in norepinephrine concentration make shunting a more likely explanation. While fractional extraction and pulmonary clearance of norepinephrine significantly decreased during hypoxia, net pulmonary norepinephrine removal also decreased significantly but to a lesser degree. The absence of a larger decrease in net pulmonary norepinephrine removal may be explained by an increase in substrate delivery during the hypoxic period. Spillover, an indirect index of pulmonary sympathetic activity, was variable between animals and did not change with hypoxia. The lack of an increase in pulmonary norepinephrine spillover was unexpected. The pulmonary vasculature has a rich sympathetic innervation and sympathectomy abolishes the pulmonary vasoconstriction response to hypoxia in lambs of this age but not older animals (28) . The lack of increase in norepinephrine spillover could suggest that pulmonary sympathetic activity does not increase with this degree of hypoxia, or might be related to altered blood flow distribution in the areas of sympathetic vasoconstriction and lack of norepinephrine washout from innervated, lesser perfused areas. Finally, the spillover data may relate in part to the sensitivity of the use of blood samples to detect altered norepinephrine secretion kinetics at the actual neuroeffector junction.
In summary, the pulmonary vascular bed of I-wk-old lambs extracts 20-25% of norepinephrine from the circulation. This extraction represents a contribution of over 70% to whole body clearance. With acute hypoxia, the pulmonary arterial pressures and pulmonary vascular resistance increase. The fractional extraction of norepinephrine and pulmonary norepinephrine clearance decrease. It is unclear from these data whether a greater impairment of pulmonary norepinephrine clearance would result from greater degrees of hypoxia and/or asphyxia. Decreased pulmonary norepinephrine clearance may result in increased norepinephrine delivery to resistance vessels within the pulmonary vasculature and to the systemic circulation and may contribute to the lability of vascular resistance in the neonatal period.
